Dialysis Equipment Market Report Scope & Overview:

The Dialysis Equipment Market was valued at USD 107.10 Billion in 2025 and is expected to reach USD 245.51 Billion by 2035, growing at a CAGR of 8.65% from 2026 to 2035.

Kidney failure has become one of the more persistent chronic disease burdens worldwide, and dialysis remains the primary lifeline for patients whose kidneys can no longer filter blood on their own. Growing rates of chronic kidney disease and end-stage renal disease, driven in large part by rising diabetes and hypertension, are keeping demand for both hemodialysis and peritoneal dialysis equipment on a steady upward path. Healthcare systems in developing countries are investing more in dialysis infrastructure, developed countries continue to offer supportive reimbursement for treatment, and a growing elderly population is adding further pressure on an already-stretched renal care system.

The International Society of Nephrology reported that more than 3.5 million patients worldwide were receiving regular dialysis therapy as of 2024, a number projected to surpass 5.4 million by 2030, directly fueling demand for hemodialysis machines, dialyzers, peritoneal dialysis cyclers, and related consumables.

Market Size and Forecast:

• Market Size in 2026E: USD 116.36 Billion

• Market Size by 2035: USD 245.51 Billion

• CAGR: 8.65% from 2026 to 2035

• Fastest Growing Region: Asia Pacific

• Largest Region: North America

Dialysis Equipment Market Trends:

• Rising global ESRD and CKD patient numbers keep driving steady demand for hemodialysis machines, high-flux dialyzers, and peritoneal dialysis cyclers across hospital and home settings alike.

• Home hemodialysis and automated peritoneal dialysis programs are expanding fast, supported by portable device platforms and growing patient training infrastructure.

• IoT-enabled smart dialysis machines and AI-assisted session monitoring are improving treatment adequacy and helping catch adverse events earlier.

• Single-use, high-biocompatibility dialyzers and low-volume dialysate systems are gaining preference as clinics look to cut infection risk.

• Dialysis center networks are expanding across Asia-Pacific, Latin America, and the Middle East through public-private partnerships and national kidney care programs.

• Regulatory scrutiny from the FDA, CE, and national health authorities on device biocompatibility and water quality standards continues to intensify.

U.S. Dialysis Equipment Market Outlook:

The U.S. Dialysis Equipment Market was valued at approximately USD 41.77 Billion in 2025 and is expected to reach approximately USD 95.82 Billion by 2035, growing at a CAGR of approximately 8.70%.

The U.S. is the largest single-country dialysis equipment market in the world, supported by a high rate of end-stage renal disease, near-universal Medicare coverage for dialysis patients, and heavy investment in expanding home dialysis options. Federal programs are actively encouraging the shift toward home-based hemodialysis and peritoneal dialysis, which is pushing more connected, easy-to-use equipment platforms into the market.

The U.S. carries an ESRD prevalence rate of roughly 2,500 per million population, and Medicare's ESRD program covers reimbursement for more than 90% of ESRD patients nationwide. The Centers for Medicare & Medicaid Services' Kidney Care Choices model and ESRD Treatment Choices mandate are both actively encouraging home-based hemodialysis and peritoneal dialysis adoption.

Dialysis Equipment Market Segment Analysis:

• By Type, the hemodialysis equipment segment dominated the dialysis equipment market with approximately 68.42% share in 2025, while the peritoneal dialysis equipment segment is the fastest growing with a CAGR of approximately 9.82%.

• By End User, the dialysis centers and hospitals segment dominated the dialysis equipment market with approximately 71.63% share in 2025, while the home healthcare segment is the fastest growing with a CAGR of approximately 10.14%.

By Type, hemodialysis equipment dominates, peritoneal dialysis equipment grows fastest

The share of hemodialysis equipment was approximately 68.42% in the type segment in 2025 due to the prevalence of in-center hemodialysis as the standard treatment option for ESRD patients around the globe. The amount of dialyzers required during the process and the experience that physicians have gained during their years of practice regarding vascular access therapies help to maintain dominance of the segment.

The peritoneal dialysis equipment segment has shown the highest growth rate in recent years, which was about 9.82%. Factors such as the growing adoption of automated peritoneal dialysis cyclers, government campaigns on the use of home dialysis, and benefits of CAPD for kids and seniors contribute to its leadership.

By End User, dialysis centers and hospitals dominate, home healthcare grows fastest

Dialysis centers and hospitals accounted for about 71.63% of the end-user segment in 2025, largely because of the centralized treatment model, high patient throughput, standardized protocols, and capital investment capacity these settings offer. The concentration of ESRD patients in outpatient dialysis centers and hospital nephrology departments keeps demand for equipment and supplies stable in this category.

Home healthcare is expected to grow fastest, with a CAGR near 10.14% through 2035, driven by favorable CMS reforms covering home dialysis costs, rising patient demand for treatment that fits better into daily life, and expanding training programs for both patients and clinicians. Increasingly portable, easy-to-use home hemodialysis and peritoneal dialysis systems are making that shift more practical than it used to be.

Regional Analysis:

North America Dialysis Equipment Market Insights

North America dominated the global dialysis equipment market in 2025, holding roughly 39.42% of total revenue. A mature ESRD treatment environment in the United States, home to more than 7,500 outpatient dialysis facilities and a Medicare ESRD program covering more than 750,000 patients, keeps the region firmly in the lead, along with strong acceptance of technologically advanced dialysis equipment.

The United States accounts for roughly 85% of regional revenue. Federal policy initiatives like the Advancing American Kidney Health Executive Order continue to push the ESRD treatment landscape toward home-based care, creating long-term growth opportunity for portable equipment and monitoring systems, while Canada is expanding its own dialysis infrastructure through various provincial home dialysis programs.

Europe Dialysis Equipment Market Insights

Europe is the second-largest regional dialysis equipment market, supported by universal health coverage across major European economies, rigorous device assurance through CE mark regulations, and significant investment in national kidney care strategies across Germany, France, Italy, the UK, and Spain.

Germany leads regional demand, accounting for roughly 26% of European revenue, backed by strong clinical research infrastructure supporting adoption of high-flux dialyzers and online hemodiafiltration technology. GDPR-compliant connected dialysis solutions and cross-border health directives are making integrated renal care delivery and device standardization easier across the continent.

Asia Pacific Dialysis Equipment Market Insights

Asia Pacific is the fastest-growing dialysis equipment market, expanding at a CAGR near 10.42% through 2035. Exceptionally high CKD incidence across China, India, Japan, and Southeast Asia, combined with rapidly expanding dialysis center infrastructure and government investment in renal programs, is driving that growth.

China accounts for roughly 40% of regional revenue and alone contributes more than 25% of the world's dialysis patients, while India records around 230,000 new ESRD cases every year. Rising per-capita healthcare spending, improving health insurance coverage, and an expanding base of regional dialysis equipment manufacturers are all strengthening the competitive landscape across Asia Pacific.

MEA & Latin America Dialysis Equipment Market Insights

Middle East and Africa region is witnessing consistent investments in terms of dialysis infrastructure, where Saudi Arabia accounts for around 30% of the MEA revenue due to the ongoing Vision 2030 transformation within its healthcare sector. In addition, the UAE is following a similar trend, while improved mobile health connectivity within the region is contributing to increased use of home dialysis facilities.

Latin America is growing at a similar pace with Brazil accounting for around 44% of the regional revenue, owing to increased investment within the public network of dialysis centers along with the private nephrology clinics to cater to the increasing number of patients suffering from ESRD. In addition, Mexico is following a similar trend as well, while increasing numbers of diabetes and hypertension in both regions bode well for dialysis equipment.

Market Dynamics:

Growth Drivers: Rising global burden of chronic kidney disease and ESRD

The rising incidence of chronic kidney disease, now affecting an estimated 850 million people worldwide as of 2024 according to the International Society of Nephrology, is the key factor driving dialysis equipment demand. Diabetes and hypertension, the two leading causes of ESRD, affect more than 537 million and 1.3 billion adults worldwide respectively, and that growing patient pipeline waiting for renal replacement therapy keeps pushing capital spending on hemodialysis equipment, dialyzers, and peritoneal dialysis consumables higher across healthcare systems globally.

The U.S. Renal Data System reported in May 2024 that ESRD incidence in the United States grew by 4.2% year-over-year in 2023, a jump that drove a corresponding 6.8% increase in dialysis equipment procurement across dialysis center networks nationwide, a clear illustration of how directly patient growth translates into equipment demand.

Restraints: High equipment costs and reimbursement limitations

The high capital cost of advanced hemodialysis equipment, smart peritoneal dialysis cyclers, and ultra-pure water treatment systems remains a major barrier to adoption, particularly in low- and middle-income countries with limited health expenditure. Budget constraints in public health infrastructure make it genuinely difficult for many facilities to acquire the newest generation of dialysis technology.

Unclear reimbursement policy in emerging markets, along with limited insurance coverage for home dialysis supplies, compounds the problem further. High-burden developing markets such as Sub-Saharan Africa and Southeast Asia face particularly steep barriers to market acceptance, which continues to limit the overall commercial potential for advanced dialysis devices in these regions.

Opportunities: Home dialysis expansion and wearable dialysis technology

The broader shift toward patient-centric, home-based kidney care represents a genuinely significant growth opportunity, with rising investment in wearable artificial kidneys, miniaturized hemodialysis systems, and automated peritoneal dialysis platforms. Government incentives supporting home dialysis in the U.S., UK, Australia, and Canada are reinforcing that shift, and machine learning tools that help optimize dialysis prescriptions and support remote nephrologist monitoring are expected to improve patient outcomes further.

The Centers for Medicare & Medicaid Services reported in January 2025 that the share of new ESRD patients starting home dialysis in the U.S. climbed to 17.3%, up from 12.8% in 2020, a clear validation of just how much commercial opportunity exists for home hemodialysis and peritoneal dialysis equipment manufacturers heading into the next decade.

Recent Developments:

• 2025: Fresenius Medical Care launched the 6008 CAREsystem hemodialysis platform with integrated AI-assisted fluid management and remote monitoring capabilities across its European and North American clinic networks, targeting improved clinical outcomes and operational efficiency.

• 2024: Baxter International introduced the AMIA APD System with CloudConnect upgrades, enabling real-time therapy data transmission and remote patient monitoring for home peritoneal dialysis patients across the United States, Canada, and select European markets.

• 2025: Nipro Corporation expanded its ELISIO-H high-flux dialyzer production capacity at its Thailand manufacturing facility by 30%, targeting growing demand from dialysis centers across Southeast Asia and the Middle East amid rising ESRD patient volumes.

Dialysis Equipment Market key players are:

• Fresenius Medical Care AG & Co. KGaA

• Baxter International Inc.

• Nipro Corporation

• B. Braun Melsungen AG

• Nikkiso Co., Ltd.

• Asahi Kasei Medical Co., Ltd.

• Toray Medical Co., Ltd.

• Outset Medical, Inc.

• Rockwell Medical, Inc.

• Merit Medical Systems, Inc.

• Teleflex Incorporated

• Weigao Group (WEGO Medical)

• Allmed Medical Products Co., Ltd.

• AngioDynamics, Inc.

• Mar Cor Purification (Cantel Medical)

• Guangdong Biolight Meditech Co., Ltd.

• Medtronic plc

• Dirinco AG

• Isopure Corp.

• Huaren Pharmaceutical Co., Ltd.

Dialysis Equipment Market Report Scope: